Table 1.
Association between DCBLD2 mRNA expression and clinicopathological features of patients with LUAD from the TCGA database. Cut off: 12.9 FPKM, * p < 0.05, ** p < 0.01, Chi-square test.
Characteristics | Total (n = 513) |
DCBLD2 Expression | χ2 | p Value | |
---|---|---|---|---|---|
Low (n = 339) | High (n = 114) | ||||
Gender | 1.475 | 0.225 | |||
Male | 222 | 167 | 55 | ||
Female | 291 | 232 | 59 | ||
Age(year) | 0.323 | 0.570 | |||
<65 | 237 | 187 | 50 | ||
≥65 | 276 | 212 | 64 | ||
T staging | 1.679 | 0.195 | |||
T1–T2 | 446 | 351 | 95 | ||
T3–T4 | 67 | 48 | 19 | ||
Nodal staging | 7.360 | 0.007 ** | |||
N0 | 338 | 275 | 63 | ||
N1–N3 | 175 | 124 | 51 | ||
M staging | 0.589 | 0.443 | |||
M0 | 488 | 378 | 110 | ||
M1 | 25 | 21 | 4 | ||
TNM | 6.063 | 0.014 * | |||
I | 277 | 227 | 50 | ||
II,III,IV | 236 | 172 | 64 |